vs
Side-by-side financial comparison of APTARGROUP, INC. (ATR) and Genius Sports Ltd (GENI). Click either name above to swap in a different company.
APTARGROUP, INC. is the larger business by last-quarter revenue ($962.7M vs $510.9M, roughly 1.9× Genius Sports Ltd). APTARGROUP, INC. runs the higher net margin — 7.7% vs -12.3%, a 20.1% gap on every dollar of revenue. APTARGROUP, INC. produced more free cash flow last quarter ($96.9M vs $69.6M). Over the past eight quarters, Genius Sports Ltd's revenue compounded faster (129.2% CAGR vs 2.6%).
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
Genius Sports is a sports data and technology company that provides data management, video streaming and integrity services to sports leagues, bookmakers and media companies.
ATR vs GENI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $962.7M | $510.9M |
| Net Profit | $74.3M | $-63.0M |
| Gross Margin | — | 25.2% |
| Operating Margin | 11.0% | -11.5% |
| Net Margin | 7.7% | -12.3% |
| Revenue YoY | 13.5% | — |
| Net Profit YoY | -26.4% | — |
| EPS (diluted) | $1.13 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $962.7M | $510.9M | ||
| Q3 25 | $961.1M | $335.4M | ||
| Q2 25 | $966.0M | $215.2M | ||
| Q1 25 | $887.3M | $119.7M | ||
| Q4 24 | $848.1M | $413.0M | ||
| Q3 24 | $909.3M | $285.8M | ||
| Q2 24 | $910.1M | $184.1M | ||
| Q1 24 | $915.4M | $97.2M |
| Q4 25 | $74.3M | $-63.0M | ||
| Q3 25 | $127.9M | — | ||
| Q2 25 | $111.7M | $-47.3M | ||
| Q1 25 | $78.8M | $-25.5M | ||
| Q4 24 | $100.9M | $-85.5M | ||
| Q3 24 | $100.0M | $-47.1M | ||
| Q2 24 | $90.5M | $-35.5M | ||
| Q1 24 | $83.1M | $-25.2M |
| Q4 25 | — | 25.2% | ||
| Q3 25 | — | 24.2% | ||
| Q2 25 | — | 19.1% | ||
| Q1 25 | — | 10.7% | ||
| Q4 24 | — | 16.7% | ||
| Q3 24 | — | 20.5% | ||
| Q2 24 | — | 18.6% | ||
| Q1 24 | — | 9.8% |
| Q4 25 | 11.0% | -11.5% | ||
| Q3 25 | 14.2% | -15.3% | ||
| Q2 25 | 14.9% | -21.0% | ||
| Q1 25 | 12.8% | -20.3% | ||
| Q4 24 | 14.2% | -18.0% | ||
| Q3 24 | 15.2% | -13.9% | ||
| Q2 24 | 13.8% | -16.8% | ||
| Q1 24 | 12.2% | -23.7% |
| Q4 25 | 7.7% | -12.3% | ||
| Q3 25 | 13.3% | — | ||
| Q2 25 | 11.6% | -22.0% | ||
| Q1 25 | 8.9% | -21.3% | ||
| Q4 24 | 11.9% | -20.7% | ||
| Q3 24 | 11.0% | -16.5% | ||
| Q2 24 | 9.9% | -19.3% | ||
| Q1 24 | 9.1% | -25.9% |
| Q4 25 | $1.13 | — | ||
| Q3 25 | $1.92 | — | ||
| Q2 25 | $1.67 | — | ||
| Q1 25 | $1.17 | — | ||
| Q4 24 | $1.48 | — | ||
| Q3 24 | $1.48 | — | ||
| Q2 24 | $1.34 | — | ||
| Q1 24 | $1.23 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $409.5M | $280.6M |
| Total DebtLower is stronger | $1.1B | — |
| Stockholders' EquityBook value | $2.7B | $724.5M |
| Total Assets | $5.3B | $1.1B |
| Debt / EquityLower = less leverage | 0.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $409.5M | $280.6M | ||
| Q3 25 | $264.8M | $110.2M | ||
| Q2 25 | $169.8M | $110.2M | ||
| Q1 25 | $136.8M | $110.2M | ||
| Q4 24 | $226.2M | $100.3M | ||
| Q3 24 | $327.9M | $100.3M | ||
| Q2 24 | $223.9M | $100.3M | ||
| Q1 24 | $201.1M | $100.3M |
| Q4 25 | $1.1B | — | ||
| Q3 25 | $546.0M | — | ||
| Q2 25 | $535.1M | — | ||
| Q1 25 | $561.2M | — | ||
| Q4 24 | $688.1M | — | ||
| Q3 24 | $822.7M | — | ||
| Q2 24 | $681.5M | — | ||
| Q1 24 | $680.4M | — |
| Q4 25 | $2.7B | $724.5M | ||
| Q3 25 | $2.8B | $572.4M | ||
| Q2 25 | $2.7B | $572.4M | ||
| Q1 25 | $2.5B | $572.4M | ||
| Q4 24 | $2.5B | $573.0M | ||
| Q3 24 | $2.5B | $573.0M | ||
| Q2 24 | $2.4B | $573.0M | ||
| Q1 24 | $2.3B | $573.0M |
| Q4 25 | $5.3B | $1.1B | ||
| Q3 25 | $5.1B | $792.3M | ||
| Q2 25 | $4.9B | $792.3M | ||
| Q1 25 | $4.5B | $792.3M | ||
| Q4 24 | $4.4B | $775.7M | ||
| Q3 24 | $4.6B | $775.7M | ||
| Q2 24 | $4.5B | $775.7M | ||
| Q1 24 | $4.4B | $775.7M |
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.28× | — | ||
| Q1 24 | 0.29× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.7M | $81.9M |
| Free Cash FlowOCF − Capex | $96.9M | $69.6M |
| FCF MarginFCF / Revenue | 10.1% | 13.6% |
| Capex IntensityCapex / Revenue | 9.0% | 2.4% |
| Cash ConversionOCF / Net Profit | 2.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $299.6M | $33.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $183.7M | $81.9M | ||
| Q3 25 | $177.6M | $-4.8M | ||
| Q2 25 | $126.0M | $-1.2M | ||
| Q1 25 | $82.7M | $-14.6M | ||
| Q4 24 | $178.2M | $14.9M | ||
| Q3 24 | $229.3M | $-9.2M | ||
| Q2 24 | $143.6M | — | ||
| Q1 24 | $92.3M | — |
| Q4 25 | $96.9M | $69.6M | ||
| Q3 25 | $114.3M | $-14.2M | ||
| Q2 25 | $62.5M | $-5.8M | ||
| Q1 25 | $25.9M | $-16.0M | ||
| Q4 24 | $112.2M | $11.3M | ||
| Q3 24 | $162.7M | $-11.6M | ||
| Q2 24 | $75.4M | — | ||
| Q1 24 | $16.7M | — |
| Q4 25 | 10.1% | 13.6% | ||
| Q3 25 | 11.9% | -4.2% | ||
| Q2 25 | 6.5% | -2.7% | ||
| Q1 25 | 2.9% | -13.4% | ||
| Q4 24 | 13.2% | 2.7% | ||
| Q3 24 | 17.9% | -4.1% | ||
| Q2 24 | 8.3% | — | ||
| Q1 24 | 1.8% | — |
| Q4 25 | 9.0% | 2.4% | ||
| Q3 25 | 6.6% | 2.8% | ||
| Q2 25 | 6.6% | 2.1% | ||
| Q1 25 | 6.4% | 1.2% | ||
| Q4 24 | 7.8% | 0.9% | ||
| Q3 24 | 7.3% | 0.9% | ||
| Q2 24 | 7.5% | — | ||
| Q1 24 | 8.3% | — |
| Q4 25 | 2.47× | — | ||
| Q3 25 | 1.39× | — | ||
| Q2 25 | 1.13× | — | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | 1.77× | — | ||
| Q3 24 | 2.29× | — | ||
| Q2 24 | 1.59× | — | ||
| Q1 24 | 1.11× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
GENI
Segment breakdown not available.
